ESSA Pharma
(NASDAQ) EPIX
This security has been delisted. This page is retained for historical reference.
EPIX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowEPIX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-17%
Return on Capital
-20%
Return on Assets
-17%
Earnings Yield
N/A
Dividend Yield
839.96%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$90.68K
Operating Income
$34.42M
EBITDA
$28.45M
Operating Cash Flow
$22.72M
Capital Expenditure
$0.00
Free Cash Flow
$22.72M
Cash & ST Invst.
$126.76M
Total Debt
$329.26K
ESSA Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$16.38K
+27.7%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
35
N/A
Net Income
$4.00M
+44.7%
EBITDA
$4.98M
+30.9%
Quarterly Fundamentals
Net Cash
$109.62M
-15.9%
Accounts Receivable
$527.15K
+187.1%
Inventory
$0.00
N/A
Long Term Debt
$0.00
-100.0%
Short Term Debt
$0.00
-100.0%
Return on Assets
-17.11%
N/A
Return on Invested Capital
-20.26%
N/A
Free Cash Flow
$4.20M
+26.9%
Operating Cash Flow
$4.20M
+26.9%